These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 32088360)

  • 1. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
    Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y
    Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
    Chen BK; Luna VM; LaGamma CT; Xu X; Deng SX; Suckow RF; Cooper TB; Shah A; Brachman RA; Mendez-David I; David DJ; Gardier AM; Landry DW; Denny CA
    Neuropsychopharmacology; 2020 Aug; 45(9):1545-1556. PubMed ID: 32417852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-relevant concentrations of the ketamine metabolite (2
    Lumsden EW; Troppoli TA; Myers SJ; Zanos P; Aracava Y; Kehr J; Lovett J; Kim S; Wang FH; Schmidt S; Jenne CE; Yuan P; Morris PJ; Thomas CJ; Zarate CA; Moaddel R; Traynelis SF; Pereira EFR; Thompson SM; Albuquerque EX; Gould TD
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5160-5169. PubMed ID: 30796190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (
    Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
    Shaffer CL; Dutra JK; Tseng WC; Weber ML; Bogart LJ; Hales K; Pang J; Volfson D; Am Ende CW; Green ME; Buhl DL
    Neuropharmacology; 2019 Jul; 153():73-81. PubMed ID: 31015046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.
    Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K
    Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-dependent metabolism of ketamine and (
    Highland JN; Farmer CA; Zanos P; Lovett J; Zarate CA; Moaddel R; Gould TD
    J Psychopharmacol; 2022 Feb; 36(2):170-182. PubMed ID: 34971525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice.
    Yamagishi A; Ikekubo Y; Mishina M; Ikeda K; Ide S
    J Pharmacol Sci; 2024 Mar; 154(3):203-208. PubMed ID: 38395521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (
    Highland JN; Morris PJ; Zanos P; Lovett J; Ghosh S; Wang AQ; Zarate CA; Thomas CJ; Moaddel R; Gould TD
    J Psychopharmacol; 2019 Jan; 33(1):12-24. PubMed ID: 30488740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2
    Highland JN; Morris PJ; Konrath KM; Riggs LM; Hagen NR; Zanos P; Powels CF; Moaddel R; Thomas CJ; Wang AQ; Gould TD
    ACS Chem Neurosci; 2022 Feb; 13(4):510-523. PubMed ID: 35113535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.
    Zhao X; Venkata SL; Moaddel R; Luckenbaugh DA; Brutsche NE; Ibrahim L; Zarate CA; Mager DE; Wainer IW
    Br J Clin Pharmacol; 2012 Aug; 74(2):304-14. PubMed ID: 22295895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses.
    Zanos P; Highland JN; Liu X; Troppoli TA; Georgiou P; Lovett J; Morris PJ; Stewart BW; Thomas CJ; Thompson SM; Moaddel R; Gould TD
    Br J Pharmacol; 2019 Jul; 176(14):2573-2592. PubMed ID: 30941749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain.
    Toki H; Yamaguchi JI; Mizuno-Yasuhira A; Endo H
    J Pharm Biomed Anal; 2023 Feb; 224():115168. PubMed ID: 36473323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
    Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.
    Farmer CA; Gilbert JR; Moaddel R; George J; Adeojo L; Lovett J; Nugent AC; Kadriu B; Yuan P; Gould TD; Park LT; Zarate CA
    Neuropsychopharmacology; 2020 Jul; 45(8):1398-1404. PubMed ID: 32252062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
    Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC
    Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.
    Zhang K; Fujita Y; Hashimoto K
    Sci Rep; 2018 Mar; 8(1):4007. PubMed ID: 29507385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice.
    Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Igarashi H; Seiriki K; Nakazawa T; Kasai A; Ago Y; Hashimoto H
    J Pharmacol Sci; 2024 Feb; 154(2):72-76. PubMed ID: 38246730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model.
    Ju L; Yang J; Zhu T; Liu P; Yang J
    BMC Psychiatry; 2022 Mar; 22(1):182. PubMed ID: 35291971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice.
    Yamaguchi JI; Toki H; Qu Y; Yang C; Koike H; Hashimoto K; Mizuno-Yasuhira A; Chaki S
    Neuropsychopharmacology; 2018 Aug; 43(9):1900-1907. PubMed ID: 29802366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.